TCRT vs TXT · $5.6M cap vs P/E 19, rev $7.52B
Alaunos Therapeutics Inc (TCRT) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
TCRT currently screens at market cap $5.6M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the TCRT and TXT stock pages for the full models.
Not investment advice.